Following tireless advocacy, Carter celebrates FDA approval for Barth syndrome treatment
September 19, 2025
September 19, 2025
WASHINGTON, Sept. 19 -- Rep. Earl L. Carter, R-Georgia, issued the following news release:
* * *
Following tireless advocacy, Carter celebrates FDA approval for Barth syndrome treatment
*
WASHINGTON, D.C. - Rep. Earl L. "Buddy" Carter (R-GA) today celebrated the Food and Drug Administration's (FDA) announcement that it has granted an accelerated approval for Stealth Biotherapeutics' Barth syndrome treatment, Forzinity (elami . . .
* * *
Following tireless advocacy, Carter celebrates FDA approval for Barth syndrome treatment
*
WASHINGTON, D.C. - Rep. Earl L. "Buddy" Carter (R-GA) today celebrated the Food and Drug Administration's (FDA) announcement that it has granted an accelerated approval for Stealth Biotherapeutics' Barth syndrome treatment, Forzinity (elami . . .